$15.09
▲ +0.4% Today
as of Sep 4, 16:48 ET
Last 30 days
Recent Press Releases & News
Alpha Tau to Participate in September Investor Conferences
Alpha Tau Medical Completes Patient Enrollment in Pancreatic Cancer Study
Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions
Overview
52-week range
$3.43
$15
99% of range
Avg surprise (last 3)
-31.3%
Avg reaction (last 2)
+4.0%
50% positive
Latest IV / EM
61%
EM ±9.5% · $15 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Mon May 18, 2026 | Mar/2026 | $-0.26 | $-0.13 | -100.0% | -116.7% | -3.2% | earnings |
| Mon Aug 11, 2025 | Jun/2025 | $-0.13 | $-0.12 | -8.3% | — | — | earnings |
| Mon May 19, 2025 | Mar/2025 | $-0.12 | $-0.14 | +14.3% | — | +11.1% | earnings |